NCT00308412View on ClinicalTrials.gov

Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Paramyxoviridae InfectionsVirus Diseases
Interventions
BIOLOGICAL

rHPIV3cp45

Placebo for rHPIV3cp45 vaccine is 1X L-15.

BIOLOGICAL

Placebo

Placebo for rHPIV3cp45 vaccine

Trial Locations (1)

21205

Center for Immunization Research, Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00308412 - Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants | Biotech Hunter | Biotech Hunter